<DOC>
	<DOCNO>NCT00346879</DOCNO>
	<brief_summary>This prospective open-label study compare two dose regimen fondaparinux , use prevent deep vein thrombosis , morbidly obese volunteer .</brief_summary>
	<brief_title>Study Determine Effective Dosing Fondaparinux Obese Persons</brief_title>
	<detailed_description>The incidence obesity grow alarm pace reach epidemic proportion . Subjects 100 pound ideal body weight classify morbidly obese consider carry high risk multiple chronic medical condition impact quality life shorten life span . As result obesity , individual also high risk develop life-threatening blood clot . Such risk elevate exposure obese subject stress surgery . In fact , common cause death major surgery morbidly obese subject migration blood clot lung heart . With current rise popularity weight loss surgery , become imperative identify medication safe effective prevent formation blood clot . Fondaparinux potential effective anti-clotting drug . It superior similar drug completely utilized body , predictable action . The problem , however , recommend dos fondaparinux obtain study lean individual . This fixed dose administer universally , regardless size subject . Presently , information recommend dos morbidly obese subject , need effective anti-clotting medication . This study attempt determine whether fix dose weight-related dose appropriate morbidly obese subject , also investigate safety administer weight-based dosing individual .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<criteria>Age 1965 BMI : 3565 Negative pregnancy test day study Blood Pressure &lt; = 160/90 Temperature &gt; 37.5 C ( 99.5 F ) Nursing baby Positive pregnancy test day study . Medications : History regular treatment anticoagulant antiplatelet agent include aspirin NSAIDS ; use aspirin NSAIDS within 1 month study . Past Medical History : Cerebrovascular accident ( include transient ischemic attack ) within 6 month study . Diabetic retinopathy document positive fundoscopy previous 3 month . Active peptic ulcer disease , EGD Ba meal , within 3 month study . Known bleed disorder . Known thrombophilia History heparin induce thrombocytopenia . History bacterial endocarditis . Known hypersensitivity fondaparinux . Ulcerative colitis . History GI bleed History hematuria Recent surgery ( previous 3 month ) . Recent trauma road traffic accident ( previous 3 month ) . Laboratory Values : Platelet count &lt; = 100,000 . Hemoglobin &lt; 12g/dl woman &lt; 14g/dl men . Prothrombin time &gt; 13 Activated partial thromboplastin time ( APTT ) &gt; 35s Liver function test parameter : ALT &gt; 60u/L , AST &gt; 40u/L , Î³GT &gt; 85u/L , Alkaline phosphatase &gt; 251 u/L total bilirubin &gt; 1.3 mg/dl . Estimated urinary creatinine clearance &lt; 50 mls/min . Hematuria urine dipstick .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>fondaparinux prevention blood clot</keyword>
</DOC>